rs1554588353
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_017890.5(VPS13B):c.11571-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_017890.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Cohen syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VPS13B | NM_017890.5 | c.11571-2A>G | splice_acceptor_variant, intron_variant | Intron 60 of 61 | ENST00000358544.7 | NP_060360.3 | ||
| VPS13B | NM_152564.5 | c.11496-2A>G | splice_acceptor_variant, intron_variant | Intron 60 of 61 | ENST00000357162.7 | NP_689777.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VPS13B | ENST00000358544.7 | c.11571-2A>G | splice_acceptor_variant, intron_variant | Intron 60 of 61 | 1 | NM_017890.5 | ENSP00000351346.2 | |||
| VPS13B | ENST00000357162.7 | c.11496-2A>G | splice_acceptor_variant, intron_variant | Intron 60 of 61 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cohen syndrome Pathogenic:2
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant has been observed on the opposite chromosome (in trans) from a pathogenic variant in an individual with clinical features consistent with Cohen syndrome (Invitae). This finding is consistent with autosomal recessive inheritance, and suggests that this variant contributes to disease. This variant has not been reported in the literature in individuals with VPS13B-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 60 of the VPS13B gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Pathogenic:1
The c.11571-2 A>G variant in VPS13B has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. c.11571-2 A>G destroys the canonical splice acceptor site in intron 60. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Neither the frameshift nor splice site variant were observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating these are not common benign variants in these populations. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at